Sresta Therapeutics Private Limited (Part Ix) - Company Profile

It is a chemicals private limited company based in Hyderabad, Telangana, India, established in 2007.

2007 Hyderabad, Telangana, India Struck Off

Last Updated: July 23, 2025

About Sresta Therapeutics Private Limited (Part Ix)

Sresta Therapeutics Private Limited (Part Ix), a struck off private limited company, was established on 27 December 2007 in Hyderabad, Telangana, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230TG2007PTC056870. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M.

Its leadership includes Sumalatha Tirukkovalluri (Director), Venkata Krishna Suryaprakasa Rao Tirukkovalluri (Managing Director). Past directors included Venkata Krishna Suryaprakasa Rao Tirukkovalluri. It is based at 12-12-414/6 1St Floor St No 1 Tarnaka, Hyderabad, Telangana, 500017.

Company Details

CIN/LLPIN
U24230TG2007PTC056870
Registration Number
056870
Incorporation Date
27 December 2007
Authorized Capital
₹0.10 M
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 0.10 M as on 23-07-2025
Company Age 18 Year, 1 Month

Comprehensive Company Insights

Explore comprehensive insights into Sresta Therapeutics Private Limited (Part Ix) — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Sresta Therapeutics Private Limited (Part Ix)?

Current Directors

Name	Designation	Appointment Date	Status
Sumalatha Tirukkovalluri	Director	27 Dec 2007	Current
Venkata Krishna Suryaprakasa Rao Tirukkovalluri	Managing Director	27 Dec 2007	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	08 Jan 2008	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sresta Therapeutics(Part Ix).

Enhance accessibility to Sresta Therapeutics(Part Ix)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sresta Therapeutics(Part Ix)?

Unlock access to Sresta Therapeutics(Part Ix)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sresta Therapeutics(Part Ix)?

Unlock and access historical data on people associated with Sresta Therapeutics(Part Ix), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Sresta Therapeutics(Part Ix), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sresta Therapeutics(Part Ix)'s trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sresta Therapeutics(Part Ix)

Recent Activity within the Organization

Director Appointment

Progress on Sumalatha Tirukkovalluri was appointed as a Director was appointed as a Director on 27 Dec 2007 & has been associated with this company since 18 years 1 month . was documented.
27 Dec 2007
Director Appointment

Venkata Krishna Suryaprakasa Rao Tirukkovalluri was appointed as a Managing Director was appointed as a Managing Director on 27 Dec 2007 & has been associated with this company since 18 years 1 month . was recorded as a recent event.
27 Dec 2007
Company Incorporation

Sresta Therapeutics Private Limited (Part Ix) was registered on 27 Dec 2007 with Roc Hyderabad & aged 18 years 1 month as per MCA records. was recorded as a recent event.
27 Dec 2007

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Sresta Therapeutics Private Limited (Part Ix)?

The CIN of Sresta Therapeutics Private Limited (Part Ix) is U24230TG2007PTC056870.

Where is Sresta Therapeutics Private Limited (Part Ix) headquartered?

Sresta Therapeutics Private Limited (Part Ix) is headquartered at 12-12-414/6 1St Floor St No 1 Tarnaka, Hyderabad, Telangana, 500017.

When was Sresta Therapeutics Private Limited (Part Ix) incorporated?

Sresta Therapeutics Private Limited (Part Ix) was incorporated on 27 December 2007.

Who are the current directors of Sresta Therapeutics Private Limited (Part Ix)?

The current directors of Sresta Therapeutics Private Limited (Part Ix) are

What is the primary industry of Sresta Therapeutics Private Limited (Part Ix)?

The primary industry of Sresta Therapeutics Private Limited (Part Ix) is Chemicals.

Is Sresta Therapeutics Private Limited (Part Ix) a listed company?

Sresta Therapeutics Private Limited (Part Ix) is unlisted.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available